Seeing Is Believing
EDIT is currently covered by 17 analysts with an average price target of $9.94. This is a potential upside of $2.5 (33.6%) from yesterday's end of day stock price of $7.44.
Editas Medicine's activity chart (see below) currently has 51 price targets and 83 ratings on display. The stock rating distribution of EDIT is 11.11% SELL, 46.67% BUY and 42.22% HOLD.
Analysts average stock forecasts to be materialized ratio is 48.49% with an average time for these price targets to be met of 127.72 days.
Highest price target for EDIT is $20, Lowest price target is $8, average price target is $9.94.
Most recent stock forecast was given by GENA WANG from BARCLAYS on 29-Feb-2024. First documented stock forecast 29-Feb-2016.
Currently out of the existing stock ratings of EDIT, 5 are a SELL (11.11%), 21 are a BUY (46.67%), 19 are a HOLD (42.22%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
11
$3.56 (47.85%)
17
28 days ago
5/6 (83.33%)
$0.94 (9.34%)
235
Buy
20
$12.56 (168.82%)
35
3 months 16 days ago
1/5 (20%)
$10.16 (103.25%)
3
Buy
9
$1.56 (20.97%)
15
5 months 28 days ago
3/5 (60%)
$1.2 (15.38%)
28
Buy
14
$6.56 (88.17%)
14
6 months 15 days ago
0/6 (0%)
$5.53 (65.29%)
Buy
19
$11.56 (155.38%)
22
7 months 25 days ago
1/9 (11.11%)
$9.69 (104.08%)
617
What is EDIT (Editas Medicine) average time for price targets to be met?
Which analyst has the current highest performing score on EDIT (Editas Medicine) with a proven track record?
Which analyst has the most public recommendations on EDIT (Editas Medicine)?
Which analyst is the currently most bullish on EDIT (Editas Medicine)?
Which analyst is the currently most reserved on EDIT (Editas Medicine)?